Corporate Responsibility at Merck

Primary tabs

Corporate Responsibility at Merck

For more than a century, Merck has been inventing medicines and vaccines for the world’s most challenging diseases. And today we’re continuing to invent new approaches that save and improve lives so that people can positively contribute to a healthier and more hopeful world.

Our corporate responsibility approach is aligned with the company’s focus on invention, and underscores our commitment to overcoming the greatest obstacles to health and wellbeing, developing and rewarding our employees, protecting the environment, and operating with the highest standards of ethics and transparency.

We support public policies that advance the interests of patients, improve public health and promote access to medicines and innovation.

Visit www.MSDresponsibility.com to learn more about Corporate Responsibility at Merck.

Content from this campaign

Merck Named One of TIME’s 50 Genius Companies for Work in Ebola
We’re honored to be in the top 50 for TIME's 2018 Genius Companies for our work in Ebola. We are inspired every day by the work we do to make an impact on global health. Learn more about Merck's response to the Ebola outbreak.
Oct 18, 2018 3:00 PM ET
Merck Emergency Drone Delivery Experiment Combines Supply Chain Innovation and Corporate Responsibility
A Merck experiment flying drones carrying medicines to remote locations to see if the technology is viable during emergencies may have appeal in disaster situations. The pilot tests are innovative not just because they involve unmanned aerial vehicles but because of the technology-enabled, real-time, cold-chain monitoring systems on board. In simple terms, a device like a mobile phone...
Sep 7, 2018 11:00 AM ET
Merck Foundation Supports New Programs to Improve Care for Alzheimer’s Patients and Caregivers in the United States
KENILWORTH, N.J., August 15, 2018 /3BL Media/ -- The Merck Foundation (the Foundation) is supporting two new programs to improve the health and wellbeing of vulnerable individuals living with Alzheimer’s disease and their caregivers. With a focus on underserved rural and urban populations in New England and Minnesota, these programs are part of the Foundation’s $5 million effort to reduce...
Aug 15, 2018 9:15 AM ET
Merck Foundation and Marshall Health Announce New Initiative to Address Opioid Epidemic in West Virginia
KENILWORTH, N.J., August 1, 2018 /3BL Media/ – The Merck Foundation (the Foundation) is supporting a new initiative with Marshall Health to launch the Great Rivers Regional System for Addiction Care (the System) to address areas hit hardest by the opioid epidemic in West Virginia. With a $2 million grant from the Foundation payable over four years, the System is an innovative,...
Aug 1, 2018 8:45 AM ET
Merck Reinforces Commitment to Responsible Pricing
KENILWORTH, N.J., July 20, 2018 /3BL Media/ -- Merck (NYSE:MRK), known as MSD outside the United States and Canada, has a long history of responsible pricing. In 2017, Merck issued its second annual Pricing Action Transparency Report, which showed that net prices across Merck’s U.S. product portfolio declined by 1.9 percent. We believe that further changes are still necessary to help reduce...
Jul 20, 2018 9:25 AM ET

Pages